These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6850693)

  • 1. [Arrhythmogenic anti-arrhythmia agents].
    Löllgen H; Hust MH; Nitsche K; Wollschläger H; Bonzel T; Just H
    Cardiology; 1983; 70 Suppl 1():129-37. PubMed ID: 6850693
    [No Abstract]   [Full Text] [Related]  

  • 2. Worsening of arrhythmias during pharmacological treatment.
    Furlanello F; Gramegna L; Dal Forno P; Vergara G; Bettini R; Inama G; Disertori M
    G Ital Cardiol; 1984 Oct; 14(10):798-803. PubMed ID: 6440827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flecainide-induced aggravation of ventricular arrhythmias.
    Wehr M; Noll B; Krappe J
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1643-4. PubMed ID: 4003313
    [No Abstract]   [Full Text] [Related]  

  • 4. [Variants of arrhythmogenic action of anti-arrhythmia agents identified during choice of therapy by a transesophageal electrophysiological study].
    Rychkov AIu; Shurin MS; Shakhov GG
    Kardiologiia; 1993; 33(1):87-9. PubMed ID: 8035557
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Jaundice caused by ajmaline: pathogenetic theory concerning 5 cases].
    Giani E; Cestari C; Lomazzi A; Magni S; Pioltelli P; Ratti L; Dinelli CA
    Clin Ter; 1981 Oct; 99(2):155-64. PubMed ID: 7318369
    [No Abstract]   [Full Text] [Related]  

  • 7. Noninvasive techniques in the evaluation of the arrhythmogenic effects.
    Rydén L
    Eur Heart J; 1988 Feb; 9 Suppl B():19-23. PubMed ID: 3286263
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intoxication with antiarrythmica (author's transl)].
    Binder C; Wimmer M
    Padiatr Padol; 1972; 7(1):46-9. PubMed ID: 4672090
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic fashion and publication bias: the case of anti-arrhythmic drugs in heart attack.
    Hampton J
    J R Soc Med; 2015 Oct; 108(10):418-20. PubMed ID: 26459066
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of cardiac arrhythmias with N-propyl-ajmalinium-hydrogentartrat (Neo-Gilurytmal (author's transl)].
    So CS; Oversohl K; Seidl KF
    Med Klin; 1974 May; 69(18):814-7. PubMed ID: 4134646
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arrhythmogenic effects of anti-arrhythmia agents].
    Fillette F; Dupuis B; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1532-4. PubMed ID: 3099688
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cases of the dangerous arrhythmogenic action of ethacizine].
    Zabela PV; Sheshkiavichius AIu; Stankiavichius RIu; Shileĭkis VR; Sherenene AK
    Ter Arkh; 1989; 61(8):119-23. PubMed ID: 2588156
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adverse effects of recent ventricular anti-arrhythmia drug].
    Raynaud R; Brochier M; Fauchier JP; Raynaud P
    Vie Med Can Fr; 1972 Feb; 1(2):127-39. PubMed ID: 4637391
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proarrhythmic effects of anti-arrhythmia agents].
    Enrico JF; Kehtari R
    Rev Med Suisse Romande; 1998 Aug; 118(8):671-90. PubMed ID: 9838826
    [No Abstract]   [Full Text] [Related]  

  • 15. The validity of the recommended criteria for termination of the ajmaline test in diagnosing Brugada syndrome.
    Meregalli PG; Veltmann C
    Heart Rhythm; 2009 Aug; 6(8):e1; author reply e1-2. PubMed ID: 19632622
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of lorcainide on the ECG pattern and left ventricular function in a patient with recurrent ventricular tachycardia].
    Sniezek-Maciejewska M; Bryniarski L; Mazurek S; Dubiel JP
    Kardiol Pol; 1990; 33(9-10):28-31. PubMed ID: 2074642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative characteristics of arrhythmogenic effects of anti-arrhythmia agents].
    Kurbanov RD
    Kardiologiia; 1991 Feb; 31(2):92-5. PubMed ID: 2041302
    [No Abstract]   [Full Text] [Related]  

  • 18. New method for the assessment of drug-induced arrhythmia aggravation.
    Andresen D; Wegscheider K; Von Leitner ER; Schröder R
    Am J Cardiol; 1988 Nov; 62(13):966-8. PubMed ID: 3177242
    [No Abstract]   [Full Text] [Related]  

  • 19. Arrhythmogenic effects of antiarrhythmic drugs.
    Maggioni AP; Cavalli A; Latini R; Tognoni G; Volpi A
    Adverse Drug React Acute Poisoning Rev; 1986; 5(4):203-14. PubMed ID: 3548269
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
    Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
    Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.